Impact, orthodoxy and peer review

British Journal of Clinical Pharmacology

Volumn 72, Issue 3, 2011, Pages 367-368

  Ritter, J M ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; INSULIN ANTIBODY; IODINE 131;

CITATION ANALYSIS; CLINICAL PHARMACOLOGY; DIABETES MELLITUS; DRUG CLEARANCE; DRUG LABELING; EDITORIAL; HUMAN; MATURITY ONSET DIABETES MELLITUS; MEDICAL LITERATURE; PEER REVIEW; PRIORITY JOURNAL; PUBLICATION; QUANTITATIVE ANALYSIS; RADIOIMMUNOASSAY; STATISTICAL ANALYSIS;

JOURNAL IMPACT FACTOR; PEER REVIEW; PEER REVIEW, RESEARCH; PUBLISHING;

EID: 79961133152     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2011.04062.x     Document Type: Editorial

References (6)

1. Colquhoun D. Lectures on Biostatistics. Oxford: Oxford University Press, 1971.
2. Garfield E originally published in the Current Contents print editions June 20, 1994, when Thomson Reuters was known as The Institute for Scientific Information® (ISI®). The Thompson Reuters impact factor. Available at: (last accessed 10 July 2011).
3. Davenas E, Beauvais F, Amara J, Oberbaum M, Robinzon B, Miadonna A, Tedeschi A, Pomeranz B, Fortner P, Belon P, Saintelaudy J, Poitevin B, Benveniste J. Human basophil de-granulation triggered by very dilute antiserum against IgE. Nature 1988; 333: 816-8.
4. Benveniste J. Wikipedia. Available at: (last accessed 10 July 2011).
5. Yalow RS. Radioimmunoassay: a probe for fine structure of biologic systems. Nobel Lecture, 8 December, 1977. Available at: (last accessed 10 July 2011).
6. th June 2011 page 31.